The middlemen that comprise a growing share of America’s convoluted health care system find themselves in a bind. The public is angry about the inflated costs and opaque dealings that govern their access to medical care. Lawmakers, despite recent setbacks, are eager to respond. Intermediaries have become an obvious target for blame and reform.